Artiva Biotherapeutics Inc. (ARTV) Live Share Price, Invest From India

Artiva Biotherapeutics Inc. Stock Performance

as on June 17, 2026 at 2:16 pm IST

Day's Low
Day's High
$8.54
Day's Price Range
$9.19
$8.91
4.15%
Downside
3.14%
Upside
52 Week's Low
52 Week's High
$1.47
52-Week Price Range
$14.53
$8.91
83.50%
Downside
63.08%
Upside

Artiva Biotherapeutics Inc. share price movements today

Previous Close: $9.18
Open: $9.01
Volume: 974.6K
Day's Low - High: $8.54 - $9.19
52 Week Low - High: $1.47 - $14.53

Artiva Biotherapeutics Inc. Historical Returns

1 Month Return: -8.9 %
3 Month Return: + 40.98 %
1 Year Return: + 395 %
3 Year Return: 0 %
5 Year Return: 0 %

Artiva Biotherapeutics Inc. Stock Fundamentals & Key Indicators

Check Artiva Biotherapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$446.0M

EPS (TTM)

-2.4325

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-67.86%

Artiva Biotherapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Artiva Biotherapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Artiva Biotherapeutics Inc.	NA	$446.0M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$38.4B	63.66%	72.49	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$114.3B	140.59%	26.73	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$64.5B	14.69%	15.02	29.65%	0.58%

Stock Returns calculator for Artiva Biotherapeutics Inc. Stock including INR - Dollar returns

The Artiva Biotherapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Artiva Biotherapeutics Inc. investment value today

Current value as on today

₹5,45,192

Returns

₹4,45,192

(+445.19%)

Returns from Artiva Biotherapeutics Inc. Stock

₹3,95,000 (+395%)

Dollar Impact

₹50,192 (+50.19%)

Indian Investors' Interest in Artiva Biotherapeutics Inc. Stock

Search interest for Artiva Biotherapeutics Inc. Stock has increased by 789% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 18, 2026 to June 17, 2026

Change:789% versus previous 30 day period

Artiva Biotherapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	2	0	-	-	-	-	-	-	-	-
Gross Profit	2	0	-	-	-	-	-	0	0	0
Operating Income	-11	-14	-16	-18	-18	-22	-22	-22	-21	-24
EBITDA	-11	-13	-17	-16	-8	-19	-20	-20	-20	-22
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-11	-13	-17	-17	-9	-20	-21	-21	-20	-23
Income Tax Expense	0	0	-1	-	-	-	-	-	-	-
Net Income	-11	-13	-17	-17	-9	-20	-21	-21	-20	-23
Net Profit Margin	-510.55%	-5562.95%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Artiva Biotherapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	2	4	33	0	-
Gross Profit	-	2	4	33	0	-2
Operating Income	-18	-53	-59	-30	-67	-90
EBITDA	-17	-71	-57	-25	-56	-81
Interest Expense	0	-	-	-	-	-
Depreciation	0	0	1	2	2	2
Income Before Tax	-17	-71	-58	-27	-58	-83
Income Tax Expense	0	-18	0	0	-	-
Net Income	-17	-71	-58	-27	-58	-83
Net Profit Margin	0.00%	-3587.66%	-1184.10%	-82.69%	-23303.98%	0.00%

Artiva Biotherapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-13	-17	-17	-16	-20	-21	-21	-20	-23
Operating Cash Flow	-15	-13	-11	-14	-19	-22	-19	-14	-20
Investing Cash Flow	9	1	-130	0	9	21	16	16	15
Financing Cash Flow	-	-1	163	0	0	0	0	0	0
Change in Cash	-5	-13	21	-15	-9	-1	-2	1	-5

Artiva Biotherapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-71	-58	-28	-65	-83
Operating Cash Flow	-15	-50	-47	-55	-76
Investing Cash Flow	-1	-6	-25	-120	63
Financing Cash Flow	152	-1	24	162	0
Change in Cash	135	-58	-49	-13	-13

Global Institutional Holdings in Artiva Biotherapeutics Inc.

Funds	Holdings
RA Capital Management, LLC	20.28%
5AM Venture Management, LLC	4.84%
venBio Partners LLC	1.09%
State Street Corp	0.07%
Velan Capital Investment Management LP	0.1%

See all

Insights on Artiva Biotherapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ARTV stock has moved up by 23.7%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ARTV has outperformed top 5 stocks with highest market-cap in its industry

About Artiva Biotherapeutics Inc.

Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. The company also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.

Organisation	Artiva Biotherapeutics Inc.
Headquarters	5505 Morehouse Drive, San Diego, CA, United States, 92121
Industry	Biotechnology
CEO	Dr. Fred Aslan M.D.
E-voting on shares	Click here to vote

Key Management of Artiva Biotherapeutics Inc.

Name	Title
Mr. Andrew Cronauer	VP, General Counsel & Corporate Secretary
Mr. Benjamin Dewees	Senior Vice President of Regulatory Affairs
Dr. Fred Aslan M.D.	CEO, Principal Financial & Accounting Officer and Director
Mr. Christopher P. Horan	Chief Technical Operations Officer
Dr. Peter Flynn Ph.D.	Co-Founder & Strategic Advisor
Dr. Nicholas Veomett Ph.D.	Vice President of Corporate Development
Dr. Heather Raymon Ph.D.	Senior Vice President of Research & Early Development
Dr. David Moriarty Ph.D.	Senior VP of Clinical Operations
Dr. Gines Diego Miralles M.D.	President and Head of Research & Development
Ms. Jennifer Kinsbruner Bush Esq., J.D.	Chief Operating Officer

FAQs

What is Artiva Biotherapeutics Inc. share price today?

Artiva Biotherapeutics Inc. share price today is $8.91 as on June 17, 2026 at 8:46 am IST at the close of the market. Artiva Biotherapeutics Inc. share today touched a day high of $9.19 and a low of $8.54.

What is the 52 week high and 52 week low for Artiva Biotherapeutics Inc. share?

Artiva Biotherapeutics Inc. share touched a 52 week high of $14.53 on April 20, 2026 and a 52 week low of $1.47 on June 27, 2025. Artiva Biotherapeutics Inc. stock price today i.e. June 17, 2026 at 8:46 am IST is closed at $8.91,which is 38.68% down from its 52 week high and 506.12% up from its 52 week low.

What is Artiva Biotherapeutics Inc.'s market capitalisation today?

Artiva Biotherapeutics Inc. market capitalisation is $0.00T as on June 17, 2026 at 8:46 am IST.

How to invest in Artiva Biotherapeutics Inc. Stock (ARTV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Artiva Biotherapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Artiva Biotherapeutics Inc. Shares that will get you 0.1684 shares as per Artiva Biotherapeutics Inc. share price of $8.91 per share as on June 17, 2026 at 8:46 am IST.

What is the minimum amount required to buy Artiva Biotherapeutics Inc. Stock (ARTV) from India?

Indian investors can start investing in Artiva Biotherapeutics Inc. (ARTV) shares with as little as ₹94.55 or $1 (as of June 17, 2026 at 8:51 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹945.50 in Artiva Biotherapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on June 17, 2026 at 8:51 am IST). Based on Artiva Biotherapeutics Inc. share’s latest price of $8.91 as on June 17, 2026 at 8:46 am IST, you will get 1.1223 shares of Artiva Biotherapeutics Inc.. Learn more about fractional shares .